In this study, we demonstrated the relationship between the infiltration level of CD103+CD8+ TRMs and clinicopathological characteristics, such as TNM stage, VEGF expression, KRAS mutant, and BRAF mutant in CRC. This evidence concerns the gene KRAS and colorectal carcinoma.